Approaching an age of reason with antiplatelet therapy

被引：3

作者：

Ajani, Andrew E. ^{[1
]}

Lefkovits, Jeffrey ^{[1
]}

机构：

[1] Royal Melbourne Hosp, Dept Cardiol, Parkville, Vic 3050, Australia

来源：

LANCET | 2008年 / 371卷 / 9621期

关键词：

D O I：

10.1016/S0140-6736(08)60573-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1315 / 1316

页数：2

共 11 条

[1]

King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002

[2] Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions -: Appropriateness of including bleeding as a component of a quadruple end point [J].

Ndrepepa, Gjin ;

Berger, Peter B. ;

Mehilli, Julinda ;

Seyfarth, Melchior ;

Neumann, Franz-Josef ;

Schoemig, Albert ;

Kastrati, Adnan .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (07) :690-697

[3] Pharmacology of CS-747 (Prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity [J].

Niitsu, Y ;

Jakubowski, JA ;

Sugidachi, A ;

Asai, F .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (02) :184-194

[4] Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel [J].

Payne, Christopher D. ;

Li, Ying Grace ;

Small, David S. ;

Ernest, C. Steven, II ;

Farid, Nagy A. ;

Jakubowski, Joseph A. ;

Brandt, John T. ;

Salazar, Daniel E. ;

Winters, Kenneth J. .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) :555-562

[5] Assessment of bleeding events in clinical trials - Proposal of a new classification [J].

Serebrulany, Victor L. ;

Atar, Dan .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (02) :288-290

[6] Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease [J].

Wallentin, Lars ;

Varenhorst, Christoph ;

James, Stefan ;

Erlinge, David ;

Braun, Oscar Oe ;

Jakubowski, Joseph A. ;

Sugidachi, Atsuhiro ;

Winters, Kenneth J. ;

Siegbahn, Agneta .

EUROPEAN HEART JOURNAL, 2008, 29 (01) :21-30

[7] Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial [J].

Wiviott, Stephen D. ;

Braunwald, Eugene ;

McCabe, Carolyn H. ;

Horvath, Ivan ;

Keltai, Matyas ;

Herrman, Jean-Paul R. ;

Van de Werf, Frans ;

Downey, William E. ;

Scirica, Benjamin M. ;

Murphy, Sabina A. ;

Antman, Elliott M. .

LANCET, 2008, 371 (9621) :1353-1363

[8] Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention - The prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial [J].

Wiviott, Stephen D. ;

Trenk, Dietmar ;

Frelinger, Andrew L. ;

O'Donoghue, Michelle ;

Neumann, Franz-Josef ;

Michelson, Alan D. ;

Angiolillo, Dominick J. ;

Hod, Hanoch ;

Montalescot, Gilles ;

Miller, Debra L. ;

Jakubowski, Joseph A. ;

Cairns, Richard ;

Murphy, Sabina A. ;

McCabe, Carolyn H. ;

Antman, Elliott M. ;

Braunwald, Eugene .

CIRCULATION, 2007, 116 (25) :2923-2932

[9] Prasugrel versus clopidogrel in patients with acute coronary syndromes [J].

Wiviott, Stephen D. ;

Braunwald, Eugene ;

McCabe, Carolyn H. ;

Montalescot, Gilles ;

Ruzyllo, Witold ;

Gottlieb, Shmuel ;

Neumann, Franz-Joseph ;

Ardissino, Diego ;

De Servi, Stefano ;

Murphy, Sabina A. ;

Riesmeyer, Jeffrey ;

Weerakkody, Govinda ;

Gibson, C. Michael ;

Antman, Elliott M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) :2001-2015

[10]

Yusuf S, 2006, NEW ENGL J MED, V354, P1464

← 1 2 →